The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, N. D.
Right arrow Articles by Wood, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, N. D.
Right arrow Articles by Wood, K. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Heart Transplantation
The Journal of Immunology, 2000, 165: 1111-1118.
Copyright © 2000 by The American Association of Immunologists

CD40-CD40 Ligand-Independent Activation of CD8+ T Cells Can Trigger Allograft Rejection1

Nick D. Jones2, Andre Van Maurik, Masaki Hara3, Bernd M. Spriewald, Oliver Witzke, Peter J. Morris and Kathryn J. Wood

Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.

In experimental transplantation, blockade of CD40-CD40 ligand (CD40L) interactions has proved effective at permitting long-term graft survival and has recently been approved for clinical evaluation. We show that CD4+ T cell-mediated rejection is prevented by anti-CD40L mAb therapy but that CD8+ T cells remain fully functional. Furthermore, blocking CD40L interactions has no effect on CD8+ T cell activation, proliferation, differentiation, homing to the target allograft, or cytokine production. We conclude that CD40L is not an important costimulatory molecule for CD8+ T cell activation and that following transplantation donor APC can activate recipient CD8+ T cells directly without first being primed by CD4+ T cells.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Yuan, M. J. Ansari, F. D'Addio, J. Paez-Cortez, I. Schmitt, M. Donnarumma, O. Boenisch, X. Zhao, J. Popoola, M. R. Clarkson, et al.
Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells
PNAS, June 30, 2009; 106(26): 10734 - 10739.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. C. Gondek, V. DeVries, E. C. Nowak, L.-F. Lu, K. A. Bennett, Z. A. Scott, and R. J. Noelle
Transplantation Survival Is Maintained by Granzyme B+ Regulatory Cells and Adaptive Regulatory T Cells
J. Immunol., October 1, 2008; 181(7): 4752 - 4760.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Haspot, T. Fehr, C. Gibbons, G. Zhao, T. Hogan, T. Honjo, G. J. Freeman, and M. Sykes
Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway
Blood, September 1, 2008; 112(5): 2149 - 2155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. L. Ford, M. E. Wagener, S. S. Hanna, T. C. Pearson, A. D. Kirk, and C. P. Larsen
A Critical Precursor Frequency of Donor-Reactive CD4+ T Cell Help Is Required for CD8+ T Cell-Mediated CD28/CD154-Independent Rejection
J. Immunol., June 1, 2008; 180(11): 7203 - 7211.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhai, Y. Wang, Z. Wu, and J. W. Kupiec-Weglinski
Defective Alloreactive CD8 T Cell Function and Memory Response in Allograft Recipients in the Absence of CD4 Help
J. Immunol., October 1, 2007; 179(7): 4529 - 4534.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. H. Horne, M. A. Koester, K. Jayashankar, K. E. Lunsford, H. L. Dziema, and G. L. Bumgardner
Disparate Primary and Secondary Allospecific CD8+ T Cell Cytolytic Effector Function in the Presence or Absence of Host CD4+ T Cells
J. Immunol., July 1, 2007; 179(1): 80 - 88.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. L. Ford, B. H. Koehn, M. E. Wagener, W. Jiang, S. Gangappa, T. C. Pearson, and C. P. Larsen
Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation
J. Exp. Med., February 19, 2007; 204(2): 299 - 309.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. D. Jones, M. Carvalho-Gaspar, S. Luo, M. O. Brook, L. Martin, and K. J. Wood
Effector and Memory CD8+ T Cells Can Be Generated in Response to Alloantigen Independently of CD4+ T Cell Help
J. Immunol., February 15, 2006; 176(4): 2316 - 2323.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. A. Nanji, W. W. Hancock, B. Luo, C. D. Schur, R. L. Pawlick, L. F. Zhu, C. C. Anderson, and A.M. J. Shapiro
Costimulation Blockade of Both Inducible Costimulator and CD40 Ligand Induces Dominant Tolerance to Islet Allografts and Prevents Spontaneous Autoimmune Diabetes in the NOD Mouse
Diabetes, January 1, 2006; 55(1): 27 - 33.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
W Chalermskulrat, K P McKinnon, W J Brickey, I P Neuringer, R C Park, D G Sterka, B R Long, P McNeillie, R J Noelle, J P Ting, et al.
Combined donor specific transfusion and anti-CD154 therapy achieves airway allograft tolerance
Thorax, January 1, 2006; 61(1): 61 - 67.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. E. Lunsford, M. A. Koester, A. M. Eiring, P. H. Horne, D. Gao, and G. L. Bumgardner
Targeting LFA-1 and CD154 Suppresses the In Vivo Activation and Development of Cytolytic (CD4-Independent) CD8+ T Cells
J. Immunol., December 15, 2005; 175(12): 7855 - 7866.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Karim, G. Feng, K. J. Wood, and A. R. Bushell
CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation
Blood, June 15, 2005; 105(12): 4871 - 4877.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Yamada, A. D. Salama, M. Sho, N. Najafian, T. Ito, J. P. Forman, R. Kewalramani, S. Sandner, H. Harada, M. R. Clarkson, et al.
CD70 Signaling Is Critical for CD28-Independent CD8+ T Cell-Mediated Alloimmune Responses In Vivo
J. Immunol., February 1, 2005; 174(3): 1357 - 1364.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Kreisel, A. M. Krasinskas, A. S. Krupnick, A. E. Gelman, K. R. Balsara, S. H. Popma, M. Riha, A. M. Rosengard, L. A. Turka, and B. R. Rosengard
Vascular Endothelium Does Not Activate CD4+ Direct Allorecognition in Graft Rejection
J. Immunol., September 1, 2004; 173(5): 3027 - 3034.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. van Maurik, B. F. de St. Groth, K. J. Wood, and N. D. Jones
Dependency of Direct Pathway CD4+ T Cells on CD40-CD154 Costimulation Is Determined by Nature and Microenvironment of Primary Contact with Alloantigen
J. Immunol., February 15, 2004; 172(4): 2163 - 2170.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. Chalermskulrat, I. P. Neuringer, W. J. Brickey, N. J. Felix, S. H. Randell, J. P. Ting, and R. M. Aris
Hierarchical Contributions of Allorecognition Pathways in Chronic Lung Rejection
Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 999 - 1007.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Blaha, S. Bigenzahn, Z. Koporc, M. Schmid, F. Langer, E. Selzer, H. Bergmeister, F. Wrba, J. Kurtz, C. Kiss, et al.
The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade
Blood, April 1, 2003; 101(7): 2886 - 2893.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. E. Phillips, T. G. Markees, J. P. Mordes, D. L. Greiner, and A. A. Rossini
Blockade of CD40-Mediated Signaling Is Sufficient for Inducing Islet But Not Skin Transplantation Tolerance
J. Immunol., March 15, 2003; 170(6): 3015 - 3023.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhai, L. Meng, R. W. Busuttil, M. H. Sayegh, and J. W. Kupiec-Weglinski
Activation of Alloreactive CD8+ T Cells Operates Via CD4-Dependent and CD4-Independent Mechanisms and Is CD154 Blockade Sensitive
J. Immunol., March 15, 2003; 170(6): 3024 - 3028.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Kreisel, A. S. Krupnick, K. R. Balsara, M. Riha, A. E. Gelman, S. H. Popma, W. Y. Szeto, L. A. Turka, and B. R. Rosengard
Mouse Vascular Endothelium Activates CD8+ T Lymphocytes in a B7-Dependent Fashion
J. Immunol., December 1, 2002; 169(11): 6154 - 6161.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. v. Maurik, M. Herber, K. J. Wood, and N. D. Jones
Cutting Edge: CD4+CD25+ Alloantigen-Specific Immunoregulatory Cells That Can Prevent CD8+ T Cell-Mediated Graft Rejection: Implications for Anti-CD154 Immunotherapy
J. Immunol., November 15, 2002; 169(10): 5401 - 5404.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhai, L. Meng, F. Gao, R. W. Busuttil, and J. W. Kupiec-Weglinski
Allograft Rejection by Primed/Memory CD8+ T Cells Is CD154 Blockade Resistant: Therapeutic Implications for Sensitized Transplant Recipients
J. Immunol., October 15, 2002; 169(8): 4667 - 4673.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhai, X.-D. Shen, F. Gao, A. J. Coito, B. A. Wasowska, A. Salama, I. Schmitt, R. W. Busuttil, M. H. Sayegh, and J. W. Kupiec-Weglinski
The CD154-CD40 T Cell Costimulation Pathway Is Required for Host Sensitization of CD8+ T Cells by Skin Grafts Via Direct Antigen Presentation
J. Immunol., August 1, 2002; 169(3): 1270 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Demirci, W. Gao, X. X. Zheng, T. R. Malek, T. B. Strom, and X. C. Li
On CD28/CD40 Ligand Costimulation, Common {gamma}-Chain Signals, and the Alloimmune Response
J. Immunol., May 1, 2002; 168(9): 4382 - 4390.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. P. Fischbein, J. Yun, H. Laks, Y. Irie, M. C. Fishbein, B. Bonavida, and A. Ardehali
Role of CD8+ lymphocytes in chronic rejection of transplanted hearts
J. Thorac. Cardiovasc. Surg., April 1, 2002; 123(4): 803 - 809.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Guillot, C. Guillonneau, P. Mathieu, C. A. Gerdes, S. Menoret, C. Braudeau, L. Tesson, K. Renaudin, M. G. Castro, P. R. Lowenstein, et al.
Prolonged Blockade of CD40-CD40 Ligand Interactions by Gene Transfer of CD40Ig Results in Long-Term Heart Allograft Survival and Donor-Specific Hyporesponsiveness, But Does Not Prevent Chronic Rejection
J. Immunol., February 15, 2002; 168(4): 1600 - 1609.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. R. Jones, J. Ha, M. A. Williams, A. B. Adams, M. M. Durham, P. A. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen
The Role of the IL-2 Pathway in Costimulation Blockade-Resistant Rejection of Allografts
J. Immunol., February 1, 2002; 168(3): 1123 - 1130.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Guo, J. Wang, L. Meng, Q. Wu, O. Kim, J. Hart, G. He, P. Zhou, J. R. Thistlethwaite Jr., M.-L. Alegre, et al.
Cutting Edge: Membrane Lymphotoxin Regulates CD8+ T Cell-Mediated Intestinal Allograft Rejection
J. Immunol., November 1, 2001; 167(9): 4796 - 4800.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Ferrari-Lacraz, X. X. Zheng, Y. S. Kim, Y. Li, W. Maslinski, X. C. Li, and T. B. Strom
An Antagonist IL-15/Fc Protein Prevents Costimulation Blockade-Resistant Rejection
J. Immunol., September 15, 2001; 167(6): 3478 - 3485.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. A. Taylor, C. J. Lees, H. Waldmann, R. J. Noelle, and B. R. Blazar
Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions
Blood, July 15, 2001; 98(2): 467 - 474.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Ensminger, B. M. Spriewald, H. V. Sorensen, O. Witzke, E. G. Flashman, A. Bushell, P. J. Morris, M. L. Rose, A. Rahemtulla, and K. J. Wood
Critical Role for IL-4 in the Development of Transplant Arteriosclerosis in the Absence of CD40-CD154 Costimulation
J. Immunol., July 1, 2001; 167(1): 532 - 541.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Qian, F. Boisgerault, G. Benichou, and M. R. Dana
Blockade of CD40-CD154 Costimulatory Pathway Promotes Survival of Allogeneic Corneal Transplants
Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 987 - 994.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
H. Ito, J. Kurtz, J. Shaffer, and M. Sykes
CD4 T Cell-Mediated Alloresistance to Fully MHC-Mismatched Allogeneic Bone Marrow Engraftment Is Dependent on CD40-CD40 Ligand Interactions, and Lasting T Cell Tolerance Is Induced by Bone Marrow Transplantation with Initial Blockade of this Pathway
J. Immunol., March 1, 2001; 166(5): 2970 - 2981.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. V. Gorbachev, P. S. Heeger, and R. L. Fairchild
CD4+ and CD8+ T Cell Priming for Contact Hypersensitivity Occurs Independently of CD40-CD154 Interactions
J. Immunol., February 15, 2001; 166(4): 2323 - 2332.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. P. Fischbein, A. Ardehali, J. Yun, S. Schoenberger, H. Laks, Y. Irie, P. Dempsey, G. Cheng, M. C. Fishbein, and B. Bonavida
CD40 Signaling Replaces CD4+ Lymphocytes and Its Blocking Prevents Chronic Rejection of Heart Transplants
J. Immunol., December 15, 2000; 165(12): 7316 - 7322.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.